Corifollitropin Alfa
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09066 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gastroduodenitis | KG + DL |
| 2 | migraine disorder | KG + DL |
| 3 | peptic ulcer disease | KG + DL |
| 4 | migraine with brainstem aura | KG + DL |
| 5 | Raynaud disease | KG + DL |
| 6 | pulmonary hypertension | KG + DL |
| 7 | kyphoscoliotic heart disease | KG + DL |
| 8 | migraine with or without aura, susceptibility to | KG + DL |
| 9 | atrophoderma vermiculata | KG + DL |
| 10 | peptic esophagitis | KG + DL |
| 11 | ulerythema ophryogenesis | KG + DL |
| 12 | hypotrichosis simplex of the scalp | KG + DL |
| 13 | congenital hypotrichosis milia | KG + DL |
| 14 | alopecia | KG + DL |
| 15 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 16 | diffuse alopecia areata | KG + DL |
| 17 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 18 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 19 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 20 | coxopodopatellar syndrome | KG + DL |
| 21 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 22 | restless legs syndrome | KG + DL |
| 23 | esophageal disease | KG + DL |
| 24 | cor pulmonale | KG + DL |
| 25 | phaeochromocytoma | KG + DL |
| 26 | headache disorder | KG + DL |
| 27 | acne (disease) | KG + DL |
| 28 | trigeminal autonomic cephalalgia | KG + DL |
| 29 | respiratory failure | KG + DL |
| 30 | endolymphatic hydrops | KG + DL |
| 31 | open-angle glaucoma | KG + DL |
| 32 | adrenal gland pheochromocytoma | KG + DL |
| 33 | duodenum cancer | KG + DL |
| 34 | non-syndromic esophageal malformation | KG + DL |
| 35 | Meniere disease | KG + DL |
| 36 | idiopathic and/or familial pulmonary arterial hypertension | KG + DL |
| 37 | hyperinsulinemic hypoglycemia, familial | KG + DL |
| 38 | primary hereditary glaucoma | KG + DL |
| 39 | idiopathic pulmonary arterial hypertension | KG + DL |
| 40 | postural orthostatic tachycardia syndrome | KG + DL |
| 41 | pulmonary hypertension, primary | KG + DL |
| 42 | autosomal dominant hyperinsulinism due to Kir6.2 deficiency | KG + DL |
| 43 | diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency | KG + DL |
| 44 | autosomal recessive hyperinsulinism due to SUR1 deficiency | KG + DL |
| 45 | gastrointestinal hamartoma | KG + DL |
| 46 | disorder of carbohydrate absorption and transport | KG + DL |
| 47 | active cochleovestibular Meniere disease | KG + DL |
| 48 | active vestibular Meniere disease | KG + DL |
| 49 | active cochlear Meniere disease | KG + DL |
| 50 | multiple system atrophy | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.